Investigation of Combined Cyclodextrin and Hydrogel Formulation for Ocular Delivery of Dexamethasone Acetate by Means of Experimental Designs

Dexamethasone acetate (DXMa) has proven its efficiency to treat corneal inflammation, without a great propensity to increase intraocular pressure. Unfortunately, its poor aqueous solubility, associated with a rapid precorneal elimination, results in a low drug bioavailability and a low penetration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazet, Roseline, Choisnard, Luc, Levilly, Delphine, Wouessidjewe, Denis, Gèze, Annabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320851/
https://www.ncbi.nlm.nih.gov/pubmed/30513707
http://dx.doi.org/10.3390/pharmaceutics10040249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320851/
https://www.ncbi.nlm.nih.gov/pubmed/30513707
http://dx.doi.org/10.3390/pharmaceutics10040249

Ejemplares similares